Search Results - Feiersinger, Gertrud E

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Olaparib is effective in combination with, and as maintenance therapy after, first‐line endocrine therapy in prostate cancer cells

    Olaparib is effective in combination with, and as maintenance therapy after, first‐line endocrine therapy in prostate cancer cells by Feiersinger, Gertrud E., Trattnig, Kristina, Leitner, Peter D., Guggenberger, Fabian, Oberhuber, Alexander, Peer, Sarah, Hermann, Martin, Skvortsova, Ira, Vrbkova, Jana, Bouchal, Jan, Culig, Zoran, Santer, Frédéric R.

    Published in Molecular oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy

    Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy by Santer, Frédéric R, Erb, Holger H H, Oh, Su Jung, Handle, Florian, Feiersinger, Gertrud E, Luef, Birgit, Bu, Huajie, Schäfer, Georg, Ploner, Christian, Egger, Martina, Rane, Jayant K, Maitland, Norman J, Klocker, Helmut, Eder, Iris E, Culig, Zoran

    Published in Oncotarget
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Abstract 3: Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy

    Abstract 3: Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy by Santer, Frédéric R., Erb, Holger H.H., Oh, Su Jung, Handle, Florian, Feiersinger, Gertrud E., Luef, Birgit, Bu, Huajie, Schäfer, Georg, Ploner, Christian, Egger, Martina, Rane, Jayant K., Maitland, Norman J., Klocker, Helmut, Eder, Iris E., Culig, Zoran

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: